<VariationArchive VariationID="930111" VariationName="NM_017780.4(CHD7):c.7276del (p.Gln2426fs)" VariationType="Deletion" Accession="VCV000930111" Version="6" RecordType="classified" NumberOfSubmissions="2" NumberOfSubmitters="2" DateLastUpdated="2024-06-23" DateCreated="2020-07-04" MostRecentSubmission="2023-11-11">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="918297" VariationID="930111">
      <GeneList>
        <Gene Symbol="CHD7" FullName="chromodomain helicase DNA binding protein 7" GeneID="55636" HGNC_ID="HGNC:20626" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>8q12.2</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="8" Accession="NC_000008.11" start="60678740" stop="60868028" display_start="60678740" display_stop="60868028" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="8" Accession="NC_000008.10" start="61591323" stop="61780586" display_start="61591323" display_stop="61780586" Strand="+" />
          </Location>
          <OMIM>608892</OMIM>
          <Haploinsufficiency last_evaluated="2023-04-11" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=CHD7">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2023-04-11" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=CHD7">No evidence available</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>NM_017780.4(CHD7):c.7276del (p.Gln2426fs)</Name>
      <CanonicalSPDI>NC_000008.11:60856553:CCC:CC</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>8q12.2</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="8" Accession="NC_000008.10" start="61769113" stop="61769113" display_start="61769113" display_stop="61769113" variantLength="1" positionVCF="61769112" referenceAlleleVCF="GC" alternateAlleleVCF="G" />
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="8" Accession="NC_000008.11" start="60856554" stop="60856554" display_start="60856554" display_stop="60856554" variantLength="1" positionVCF="60856553" referenceAlleleVCF="GC" alternateAlleleVCF="G" />
      </Location>
      <OtherNameList>
        <Name>NM_017780.4(CHD7):c.7276del</Name>
        <Name>p.Gln2426fs</Name>
      </OtherNameList>
      <ProteinChange>Q2426fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000008.10" sequenceAccession="NC_000008" sequenceVersion="10" change="g.61769115del" Assembly="GRCh37">
            <Expression>NC_000008.10:g.61769115del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000008.11" sequenceAccession="NC_000008" sequenceVersion="11" change="g.60856556del" Assembly="GRCh38">
            <Expression>NC_000008.11:g.60856556del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_007009.1" sequenceAccession="NG_007009" sequenceVersion="1" change="g.182777del">
            <Expression>NG_007009.1:g.182777del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_017780.4" sequenceAccession="NM_017780" sequenceVersion="4" change="c.7276del" MANESelect="true">
            <Expression>NM_017780.4:c.7276del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_060250.2" sequenceAccession="NP_060250" sequenceVersion="2" change="p.Gln2426fs">
            <Expression>NP_060250.2:p.Gln2426fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001316690.1" sequenceAccession="NM_001316690" sequenceVersion="1" change="c.1717-5673del">
            <Expression>NM_001316690.1:c.1717-5673del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001627" Type="intron variant" DB="SO" />
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_176" sequenceAccession="LRG_176">
            <Expression>LRG_176:g.182777del</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="rs" ID="1805723571" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_017780.4(CHD7):c.7276del (p.Gln2426fs) AND CHARGE syndrome" Accession="RCV001195545" Version="8">
        <ClassifiedConditionList TraitSetID="513">
          <ClassifiedCondition DB="MedGen" ID="C0265354">CHARGE syndrome</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
            <Description DateLastEvaluated="2023-05-02" SubmissionCount="2">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2023-05-02" NumberOfSubmissions="2" NumberOfSubmitters="2" DateCreated="2020-07-04" MostRecentSubmission="2023-11-11">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic</Description>
        <ConditionList>
          <TraitSet ID="513" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="886" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Hittner Hirsch Kreh syndrome</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Colobomatous microphthalmia, heart disease, hearing loss, and mental retardation</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">CHARGE ASSOCIATION--COLOBOMA, HEART ANOMALY, CHOANAL ATRESIA, RETARDATION, GENITAL AND EAR ANOMALIES</ElementValue>
                <XRef Type="MIM" ID="214800" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">CHARGE syndrome</ElementValue>
                <XRef ID="MONDO:0008965" DB="MONDO" />
                <XRef ID="47535005" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Coloboma, heart anomaly, choanal atresia, retardation, genital and ear anomalies</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">CHARGE association</ElementValue>
                <XRef ID="47535005" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Hall-Hittner syndrome</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">CHARGE</ElementValue>
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">CHD7 disorder encompasses the entire phenotypic spectrum of heterozygous CHD7 pathogenic variants that includes CHARGE syndrome as well as subsets of features that comprise the CHARGE syndrome phenotype. The mnemonic CHARGE syndrome, introduced in the premolecular era, stands for coloboma, heart defect, choanal atresia, retarded growth and development, genital hypoplasia, ear anomalies (including deafness). Following the identification of the genetic cause of CHD7 disorder, the phenotypic spectrum expanded to include cranial nerve anomalies, vestibular defects, cleft lip and/or palate, hypothyroidism, tracheoesophageal anomalies, brain anomalies, seizures, and renal anomalies. Life expectancy highly depends on the severity of manifestations; mortality can be high in the first few years when severe birth defects (particularly complex heart defects) are present and often complicated by airway and feeding issues. In childhood, adolescence, and adulthood, decreased life expectancy is likely related to a combination of residual heart defects, infections, aspiration or choking, respiratory issues including obstructive and central apnea, and possibly seizures. Despite these complications, the life expectancy for many individuals can be normal.</Attribute>
                <XRef ID="NBK1117" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="29" />
                <XRef ID="29" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301296</ID>
                <ID Source="BookShelf">NBK1117</ID>
              </Citation>
              <Citation Type="Translational/Evidence-based" Abbrev="EuroGentest, 2011">
                <ID Source="PubMed">21407266</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG, 2013">
                <ID Source="PubMed">23519317</ID>
              </Citation>
              <XRef ID="138" DB="Orphanet" />
              <XRef ID="C0265354" DB="MedGen" />
              <XRef ID="MONDO:0008965" DB="MONDO" />
              <XRef Type="MIM" ID="214800" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="2693826" SubmissionDate="2020-05-14" DateLastUpdated="2020-07-04" DateCreated="2020-07-04">
        <ClinVarSubmissionID localKey="98065451|OMIM:214800" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001365929" DateUpdated="2020-07-04" DateCreated="2020-07-04" Type="SCV" Version="1" SubmitterName="Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine" OrgID="21766" OrganizationCategory="laboratory" OrgAbbreviation="LMM" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2019-06-05">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>The p.Gln2426SerfsX17 variant in CHD7 has not been previously reported in individuals with CHARGE syndrome and is absent from large population studies. However, this variant was confirmed to be de novo in an individual with moderate developmental delays, bilateral sensorineural hearing loss, retinal coloboma, scoliosis, and vesicoureteral reflux by the Broad Institute Rare Genomes Project. This variant is predicted to cause a frameshift, which alters the proteinâ€™s amino acid sequence beginning at position 2426 and is predicted to lead to a truncated or absent protein. Heterozygous loss of function of the CHD7 gene is an established disease mechanism in individuals with CHARGE syndrome. In summary, this variant meets criteria to be classified as pathogenic for CHARGE syndrome in an autosomal dominant manner based upon de novo occurrence, its absence from the general population, and its predicted impact on the protein. ACMG/AMP Criteria applied: PVS1, PS2, PM2.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="ModeOfInheritance">Autosomal dominant inheritance</Attribute>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="AssertionMethod">LMM Criteria</Attribute>
          <Citation>
            <ID Source="PubMed">24033266</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
              <FamilyData NumFamiliesWithVariant="1" />
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles" integerValue="1" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="CHD7" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000008.10:g.61769115delC</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="214800" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB7448406</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7332534" SubmissionDate="2023-11-09" DateLastUpdated="2023-11-11" DateCreated="2023-05-06">
        <ClinVarSubmissionID localKey="79c7f017-fad5-4e87-ac2c-f150a6f12682" localKeyIsSubmitted="1" submittedAssembly="GRCh38" />
        <ClinVarAccession Accession="SCV003922260" DateUpdated="2023-11-11" DateCreated="2023-05-06" Type="SCV" Version="2" SubmitterName="Broad Center for Mendelian Genomics, Broad Institute of MIT and Harvard" OrgID="506627" OrganizationCategory="laboratory" OrgAbbreviation="Broad RDG" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-05-02">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>The heterozygous p.Gln2426SerfsTer17 variant in CHD7 was identified by our study in one individual with developmental delay, bilateral sensorineural hearing loss, retinal coloboma, scoliosis, and vesicoureteral reflux (Broad Institute Rare Genomes Project). Trio genome analysis showed this variant to be de novo. The p.Gln2426SerfsTer17 variant in CHD7 has not been previously reported in individuals with CHARGE syndrome. This variant has also been reported in ClinVar (Variation ID: 930111) and has been interpreted as pathogenic by Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine. This variant was absent from large population studies. This variant is predicted to cause a frameshift, which alters the protein‚Äôs amino acid sequence beginning at position 2426 and leads to a premature termination codon 17 amino acids downstream. This alteration is then predicted to lead to a truncated or absent protein. Heterozygous loss of function of the CHD7 gene is an established disease mechanism in CHARGE syndrome. In summary, this variant meets criteria to be classified as pathogenic for CHARGE syndrome. ACMG/AMP Criteria applied: PVS1, PS2_Moderate, PM2_Supporting (Richards 2015).</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="ModeOfInheritance">Autosomal dominant inheritance</Attribute>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>curation</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="CHD7" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name>NM_017780.4(CHD7):c.7276del</Name>
            <Name>p.Gln2426fs</Name>
          </OtherNameList>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000008.11:g.60856556del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MONDO" ID="MONDO:0008965" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB13232620</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="7332534" TraitType="Disease" MappingType="XRef" MappingValue="MONDO:0008965" MappingRef="MONDO">
        <MedGen CUI="C0265354" Name="CHARGE syndrome" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2693826" TraitType="Disease" MappingType="XRef" MappingValue="214800" MappingRef="OMIM">
        <MedGen CUI="C0265354" Name="CHARGE syndrome" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

